Literature DB >> 16373611

Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.

Susanne Bro1, Rehannah Borup, Claus B Andersen, Flemming Moeller, Klaus Olgaard, Lars B Nielsen.   

Abstract

OBJECTIVE: Uremia accelerates formation of atherosclerosis-like lesions in apolipoprotein E-deficient (apoE(-/-)) mice. In this study, we compared gene expression patterns in classical and uremic atherosclerosis. METHODS AND
RESULTS: High-density oligonucleotide microarray analyses were performed with aortic RNA from 5/6 nephrectomized (NX) and sham-operated mice. After 12 weeks, NX apoE(-/-) mice had more atherosclerosis and 24 genes were differentially expressed as compared with sham apoE(-/-) mice. Nine genes expressed in muscle cells displayed reduced expression (3.3- to 142-fold, P<0.05), whereas osteopontin gene expression was increased 8.7-fold (P<0.05) in NX mice. Studies of NX wild-type mice suggested that the changes in NX apoE(-/-) mice were dependent on hypercholesterolemia. Nevertheless, lesioned versus nonlesioned areas of aortas from nonuremic apoE(-/-) mice with classical atherosclerosis displayed less pronounced reductions in expression of the muscle cell related genes than seen in NX apoE(-/-) mice even though the osteopontin gene expression was increased approximately 15-fold. Electron microscopy showed more vacuolized and necrotic smooth muscle cells within the media underneath both nonlesioned and lesioned intima in NX than in sham apoE(-/-) mice.
CONCLUSIONS: The results suggest that uremic vasculopathy in apoE(-/-) mice, in addition to intimal atherosclerosis, is characterized by a uremia-specific medial smooth muscle cell degeneration, which appears to be accentuated by hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373611     DOI: 10.1161/01.ATV.0000201060.47945.cb

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  6 in total

1.  Osteopontin: an emerging therapeutic target in uraemic vascular disease.

Authors:  Xin Zhang; Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

2.  Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.

Authors:  Koba A Lomashvili; Xiaonan Wang; Reidar Wallin; W Charles O'Neill
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

3.  Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.

Authors:  Lixia Zeng; Anna V Mathew; Jaeman Byun; Kevin B Atkins; Frank C Brosius; Subramaniam Pennathur
Journal:  J Biol Chem       Date:  2018-03-26       Impact factor: 5.157

4.  Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice.

Authors:  Line S Bisgaard; Markus H Bosteen; Lisbeth N Fink; Charlotte M Sørensen; Alexander Rosendahl; Christina K Mogensen; Salka E Rasmussen; Bidda Rolin; Lars B Nielsen; Tanja X Pedersen
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

5.  Uremia does not affect neointima formation in mice.

Authors:  Annemarie Aarup; Carsten H Nielsen; Line S Bisgaard; Ilze Bot; Henrik H El-Ali; Andreas Kjaer; Lars B Nielsen; Tanja X Pedersen
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

6.  Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China.

Authors:  Zhixiong Zhong; Jing Liu; Qifeng Zhang; Wei Zhong; Bin Li; Cunren Li; Zhidong Liu; Min Yang; Pingsen Zhao
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.